Amicogen Inc Market Cap ($43.78 Million)

$43.78 Million USD · ₩64.61 Billion KRW · Rank #22213

Market Cap & Net Worth: Amicogen Inc (092040)

Amicogen Inc market cap. Amicogen Inc (KQ:092040) has a market capitalization of $43.78 Million (₩64.61 Billion) as of November 3, 2026. Listed on the KQ stock exchange, this Korea-based company holds position #22213 globally and #1406 in its home market, demonstrating a -1.82% decrease in market value over the past year.

Market capitalization, also known as net worth in stock markets, is calculated by multiplying Amicogen Inc's stock price ₩917.00 by its total outstanding shares 70453258 (70.45 Million). Also see 092040 cash generation efficiency for how efficiently the company converts equity into cash flow.

Amicogen Inc Market Cap History (2015–2026)

Amicogen Inc market cap history from 2015 to 2026. Data shows change from $719.29 Million to $43.78 Million (-23.03% CAGR). Check Amicogen Inc stock price for real-time trading data and today's change.

Index Memberships

Amicogen Inc is a constituent of 2 market indices:

Index	Total Market Cap	Weight (%)	Rank by Market Cap
Kosdaq Composite Index KOSDAQ	$211.91 Billion	0.02%	#669 of 1384
Kosdaq Composite Index KQ11	$211.91 Billion	0.02%	#669 of 1384

Weight: Amicogen Inc's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.

Amicogen Inc Market Cap to Earnings & Revenue Ratios Timeline

This chart shows how Amicogen Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore how fast is Amicogen Inc growing its equity to track how rapidly the company is growing its equity base year over year.

Latest Price to Sales (P/S) Ratio

0.00x

Amicogen Inc's market cap is 0.00 times its annual revenue

Industry average: 0.57x Lower than industry average

Latest Price to Earnings (P/E) Ratio

N/A

P/E ratio not applicable due to negative or zero earnings

What These Ratios Tell Investors:

Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
Industry comparison provides context for whether the company is valued higher or lower than peers.

Year	Market Cap (USD)	Revenue (USD)	Net Income (USD)	P/S Ratio	P/E Ratio
2016	$483.32 Million	$68.97 Billion	$1.59 Billion	0.01x	0.30x
2017	$525.79 Million	$73.67 Billion	-$4.61 Billion	0.01x	N/A
2018	$750.98 Million	$94.52 Billion	$40.17 Billion	0.01x	0.02x
2019	$560.48 Million	$115.18 Billion	$86.72 Million	0.00x	6.46x
2020	$845.68 Million	$115.86 Billion	$31.60 Billion	0.01x	0.03x
2021	$699.22 Million	$124.88 Billion	$3.73 Billion	0.01x	0.19x
2022	$427.24 Million	$144.30 Billion	-$47.22 Billion	0.00x	N/A
2023	$360.95 Million	$159.90 Billion	-$23.29 Billion	0.00x	N/A
2024	$184.30 Million	$173.60 Billion	-$52.79 Billion	0.00x	N/A
2025	$85.08 Million	$41.98 Billion	-$29.96 Billion	0.00x	N/A

Competitor Companies of 092040 by Market Capitalization

Companies near Amicogen Inc in the global market cap rankings as of November 3, 2026. Also see Amicogen Inc (092040) total assets for a full breakdown of the balance sheet.

Key companies related to Amicogen Inc by market ranking:

Takeda Pharmaceutical Co Ltd ADR (NYSE:TAK): Ranked #516 globally with a market cap of $52.60 Billion USD.
GALDERMA GROUP AG (NYSE:GALDY): Ranked #536 globally with a market cap of $50.42 Billion USD.
Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #591 globally with a market cap of $45.45 Billion USD ( CN¥310.59 Billion CNY).
Takeda Pharmaceutical Company Limited (F:TKDA): Ranked #618 globally with a market cap of $43.60 Billion USD ( €37.29 Billion EUR).

Market capitalization comparison (in billions USD)

Rank	Company	Symbol	Market Cap	Price
#516	Takeda Pharmaceutical Co Ltd ADR	NYSE:TAK	$52.60 Billion	$16.65
#536	GALDERMA GROUP AG	NYSE:GALDY	$50.42 Billion	$46.55
#591	Jiangsu Hengrui Medicine Co Ltd	SHG:600276	$45.45 Billion	CN¥48.69
#618	Takeda Pharmaceutical Company Limited	F:TKDA	$43.60 Billion	€18.50

Market Capitalization of Amicogen Inc (2015–2026)

Market capitalization of Amicogen Inc from 2015 to today. Between 2015 and today, Amicogen Inc's market cap moved from $719.29 Million to $ 43.78 Million, with a yearly change of -23.03%.

Year	Market Cap	Change (%)
2026	₩43.78 Million	-48.54%
2025	₩85.08 Million	-53.83%
2024	₩184.30 Million	-48.94%
2023	₩360.95 Million	-15.52%
2022	₩427.24 Million	-38.90%
2021	₩699.22 Million	-17.32%
2020	₩845.68 Million	+50.88%
2019	₩560.48 Million	-25.37%
2018	₩750.98 Million	+42.83%
2017	₩525.79 Million	+8.79%
2016	₩483.32 Million	-32.81%
2015	₩719.29 Million	--

End of Day Market Cap According to Different Sources

On Nov 3rd, 2026 the market cap of Amicogen Inc was reported to be:

Source	Market Cap
Yahoo Finance	$43.78 Million USD
MoneyControl	$43.78 Million USD
MarketWatch	$43.78 Million USD
marketcap.company	$43.78 Million USD
Reuters	$43.78 Million USD

Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.

About Amicogen Inc

KQ:092040 Korea Drug Manufacturers - Specialty & Generic

Market Cap

$43.78 Million

₩64.61 Billion KRW

Market Cap Rank

#22213 Global

#1406 in Korea

Share Price

₩917.00

Change (1 day)

+0.11%

52-Week Range

₩822.00 - ₩3125.00

All Time High

₩22094.22